Annex I

Part A of the Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

1. (a)

   the entry for 1-methyl-cyclopropene is replaced by the following:

   Active substance	Rapporteur Member State	Co-rapporteur Member State
   ‘1-methyl-cyclopropene	NL’

2. (b)

   the entry for Mancozeb is replaced by the following:

   Active substance	Rapporteur Member State	Co-rapporteur Member State
   ‘Mancozeb	EL’

3. (c)

   the entry for Methiocarb is replaced by the following:

   Active substance	Rapporteur Member State	Co-rapporteur Member State
   ‘Methiocarb	DE’

4. (d)

   the entry for Methoxyfenozide is replaced by the following:

   Active substance	Rapporteur Member State	Co-rapporteur Member State
   ‘Methoxyfenozide	SK’

5. (e)

   the entry for Pirimicarb is replaced by the following:

   Active substance	Rapporteur Member State	Co-rapporteur Member State
   ‘Pirimicarb	SE’

6. (f)

   the entry for Pirimiphos-methyl is replaced by the following:

   Active substance	Rapporteur Member State	Co-rapporteur Member State
   ‘Pirimiphos-methyl	FR’

7. (g)

   the entry for Thiacloprid is replaced by the following:

   Active substance	Rapporteur Member State	Co-rapporteur Member State
   ‘Thiacloprid	DE’